Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. 09926
09926 logo

09926 Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
128.700
Open
125.600
VWAP
124.52
Vol
6.20M
Mkt Cap
--
Low
120.400
Amount
772.05M
EV/EBITDA(TTM)
--
Total Shares
--
EV
15.30B
EV/OCF(TTM)
--
P/S(TTM)
35.82

Events Timeline

No data

No data

News

aastocks
4.5
02-06aastocks
HKD4.3 Billion Net Inflow from Southbound Trading into TENCENT
  • Southbound Trading Inflows: TENCENT (00700.HK) saw significant Southbound Trading net inflows totaling HKD4.3 billion, while other stocks like BABA-W (09988.HK) and POP MART (09992.HK) experienced notable short selling activity.

  • Market Activity Overview: TENCENT was the most active stock in both Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect, with substantial net inflows, while stocks like XIAOMI-W and AKESO faced the highest net outflows.

  • Short Selling Statistics: The short selling ratios for TENCENT, BABA-W, and POP MART were 15.248%, 19.556%, and 27.852% respectively, indicating a high level of market speculation.

  • Overall Market Sentiment: The total Southbound Trading net outflow was HKD0, accounting for 35.67% of the total transaction amount of HKD88.42 billion, reflecting fragile market sentiment according to JPM.

aastocks
8.0
01-09aastocks
HKEX Introduces Six New Classes of Stock Options
  • New Stock Options Launch: HKEX is set to launch six new stock option classes on January 19, 2026, enhancing choices for investors in the single stock options market.

  • Included Stocks: The new options will include stocks such as ZIJIN GOLD INTL, WUXI APPTEC, BEONE MEDICINES, LAOPU GOLD, HORIZONROBOT-W, and AKESO, each with varying short selling data and ratios.

aastocks
6.5
2025-11-03aastocks
JPM Selects AKESO, HANSOH PHARMA, and WUXI APPTEC as Preferred Choices; Pharma Market Correction Offers Support for Next Year
  • Market Pullback: China healthcare stocks have seen a significant decline since early October, with the Hang Seng Healthcare Index down 12% and the CSI 300 Healthcare Index down 9%, contrasting with a minor drop in the HSI and a rise in the CSI 300 Index.

  • Contributing Factors: The pullback is attributed to increased US-China tensions, geopolitical risks leading to profit-taking by investors, and uncertainties surrounding the US Biosecure Act affecting pharmaceutical outsourcing.

  • JPMorgan's Outlook: Despite the current pullback, JPMorgan believes it will create favorable conditions for next year's performance, highlighting several top stock picks in the healthcare sector.

  • Highlighted Stocks: JPMorgan's recommended stocks include AKESO, HANSOH PHARMA, WUXI APPTEC, INNOVENT BIO, and HENGRUI PHARMA, with varying short selling ratios indicating market sentiment.

aastocks
2.0
2025-10-16aastocks
Net Inflow of HKD1.1 Billion in Southbound Trading for XIAOMI-W
  • Southbound Trading Inflows and Outflows: XIAOMI-W saw significant net inflows of HKD1.1 billion, while SMIC and GIANT BIOGENE experienced net outflows of HKD294.6 million and HKD237.7 million, respectively.

  • Short Selling Activity: Notable short selling figures included BABA-W at $2.04 billion and POP MART at $1.27 billion, with short selling ratios of 17.320% and 18.600%, respectively.

aastocks
4.0
2025-10-02aastocks
<Research>BOCOMI Releases October Stock Recommendations for China (Table)
  • Stock Ratings and Target Prices: Various companies have received buy ratings with specific target prices, including Qfin Holdings at US$58, Alibaba at US$200, and Kuaishou-W at HK$90.

  • Short Selling Activity: Significant short selling activity is noted for several stocks, with Alibaba and Kuaishou-W experiencing high short selling ratios of 15.084% and 16.078%, respectively.

aastocks
4.5
2025-10-02aastocks
<Research> BOCOMI Anticipates Continued 'Slow Bull' Market Trend in HK; Chinese Investors Display Robust Interest in AI and Other Quality Stocks
  • Market Trends: Hong Kong stocks showed an uptrend in September, supported by improved market risk appetite, resumption of China-US trade talks, and expectations of overseas interest rate cuts, particularly benefiting the tech sector.

  • Investment Insights: BOCOM International reported tightening liquidity in late August, but noted significant inflows from southbound funds in September, with a historical high of over HKD1.1 trillion YTD, indicating strong demand for quality stocks like AI-related companies.

Wall Street analysts forecast 09926 stock price to rise
0 Analyst Rating
Wall Street analysts forecast 09926 stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
BofAS
BofAS
Buy
maintain
$162.8
AI Analysis
2026-04-28
Reason
BofAS
BofAS
Price Target
$162.8
AI Analysis
2026-04-28
maintain
Buy
Reason
The analyst maintains a Buy rating on Akeso due to significant month-over-month and year-over-year sales growth of its drug cadonilimab, which saw a 249.5% increase year-over-year and 9.6% month-over-month. Additionally, the sales of ivonescimab also showed impressive growth, indicating strong performance and market demand.
UBS
Buy
maintain
2026-03-27
Reason
UBS
Price Target
2026-03-27
maintain
Buy
Reason
UBS has maintained a Buy rating for AKESO despite lowering its target price due to disappointing revenue growth and an increased net loss in the second half of 2025, which did not meet expectations.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for 09926
Unlock Now

Valuation Metrics

The current forward P/E ratio for (09926.HK) is 236.10, compared to its 5-year average forward P/E of 172.16. For a more detailed relative valuation and DCF analysis to assess 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
172.16
Current PE
236.10
Overvalued PE
558.62
Undervalued PE
-214.30

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
33.92
Current EV/EBITDA
132.60
Overvalued EV/EBITDA
242.92
Undervalued EV/EBITDA
-175.07

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
16.79
Current PS
21.50
Overvalued PS
28.69
Undervalued PS
4.89

Financials

AI Analysis
Annual
Quarterly

Whales Holding 09926

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is (09926) stock price today?

The current price of 09926 is 126.7 USD — it has decreased -6.7

What is (09926)'s business?

What is the price predicton of 09926 Stock?

Wall Street analysts forecast 09926 stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for 09926 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is (09926)'s revenue for the last quarter?

revenue for the last quarter amounts to NaN USD, decreased

What is (09926)'s earnings per share (EPS) for the last quarter?

. EPS for the last quarter amounts to USD, decreased

How many employees does (09926). have?

(09926) has 0 emplpoyees as of May 04 2026.

What is (09926) market cap?

Today 09926 has the market capitalization of 0.00 USD.